Thursday night: 2026's most promising biotechs, revealed live

Eleven private biotechs made this year's Endpoints 11. The names get read out Thursday night at the State Room, and not before.

This is your last invitation to join us for the gala dinner. Founders, investors and the editors who chose them, together in one room. 

We are also sitting down with Don Ingber, founding director of Harvard's Wyss Institute, to talk about where drug discovery is heading and where this year's class fits.

Save 10% on your gala pass. Use code E1126_10.

Can't make Boston? The virtual experience on Sept. 28 is free. Gala highlights, winner interviews and the fireside chat. Register now.